To look for more sensitive and specific markers for renal injury, several clinical trials on AKI have been conducted and suggested some promising biomarkers, including NGAL, KIM-1, IL-18, liver-type fatty acid-binding protein (L-FABP) and cystatin C [6]. The gene discussed is IL18; the disease is acute kidney injury.